- Company Overview for HALEON UK HOLDINGS (NO.2) LIMITED (11961650)
- Filing history for HALEON UK HOLDINGS (NO.2) LIMITED (11961650)
- People for HALEON UK HOLDINGS (NO.2) LIMITED (11961650)
- More for HALEON UK HOLDINGS (NO.2) LIMITED (11961650)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
12 Sep 2024 | PSC05 | Change of details for Haleon Uk Holdings Limited as a person with significant control on 24 April 2019 | |
11 Sep 2024 | CS01 | Confirmation statement made on 11 September 2024 with updates | |
11 Sep 2024 | PSC05 | Change of details for Haleon Intermediate Holdings Limited as a person with significant control on 15 December 2022 | |
22 Aug 2024 | AA | Full accounts made up to 31 December 2023 | |
20 Oct 2023 | PSC05 | Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 20 October 2023 | |
17 Oct 2023 | PSC05 | Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 19 July 2022 | |
03 Oct 2023 | AA | Full accounts made up to 31 December 2022 | |
14 Sep 2023 | CS01 | Confirmation statement made on 14 September 2023 with updates | |
11 Sep 2023 | TM01 | Termination of appointment of Tobias Hannes Hestler as a director on 11 September 2023 | |
16 Jun 2023 | CERTNM |
Company name changed glaxosmithkline consumer healthcare holdings (no.2) LIMITED\certificate issued on 16/06/23
|
|
15 May 2023 | CH02 | Director's details changed for Haleon Uk Corporate Director Limited on 31 March 2023 | |
15 May 2023 | CH02 | Director's details changed for Gsk Consumer Healthcare Holdings (No.4) Limited on 31 March 2023 | |
15 May 2023 | CH04 | Secretary's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited on 31 March 2023 | |
15 May 2023 | CH02 | Director's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited on 31 March 2023 | |
02 Mar 2023 | TM01 | Termination of appointment of Brian James Mcnamara as a director on 1 March 2023 | |
04 Jan 2023 | RESOLUTIONS |
Resolutions
|
|
19 Dec 2022 | PSC02 | Notification of Haleon Intermediate Holdings Limited as a person with significant control on 15 December 2022 | |
19 Dec 2022 | PSC07 | Cessation of Haleon Plc as a person with significant control on 15 December 2022 | |
10 Oct 2022 | CS01 | Confirmation statement made on 27 September 2022 with updates | |
15 Aug 2022 | CH01 | Director's details changed for Mr Scott Christopher Bourgeois on 18 July 2022 | |
29 Jul 2022 | PSC07 | Cessation of Pfizer Inc as a person with significant control on 17 July 2022 | |
29 Jul 2022 | PSC02 | Notification of Haleon Plc as a person with significant control on 17 July 2022 | |
21 Jul 2022 | MA | Memorandum and Articles of Association | |
20 Jul 2022 | SH08 | Change of share class name or designation | |
19 Jul 2022 | RESOLUTIONS |
Resolutions
|